Hedges Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Hedges Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$879K	Buy	+15,250	New	+$876K	0.58%	56
2025 Q4	$905K	Sell	16,775 -1,800	-10%	-$86.6K	0.64%	54
2025 Q3	$838K	Buy	18,575 +1,475	+9%	+$68.9K	0.64%	53
2025 Q2	$792K	Sell	17,100 -18,700	-52%	-$918K	0.64%	57
2025 Q1	$2.18M	Sell	35,800 -800	-2%	-$46.6K	1.43%	18
2024 Q4	$2.07M	Sell	36,600 -500	-1%	-$27.9K	1.37%	21
2024 Q3	$1.92M	Sell	37,100 -1,500	-4%	-$70.4K	1.27%	25
2024 Q2	$1.6M	Buy	38,600 +14,650	+61%	+$656K	1.15%	32
2024 Q1	$1.3M	Buy	23,950 +1,750	+8%	+$89.1K	0.91%	40
2023 Q4	$1.14M	Buy	22,200 +5,050	+29%	+$265K	0.89%	38
2023 Q3	$995K	Buy	17,150 +5,300	+45%	+$325K	0.87%	39
2023 Q2	$758K	Hold	11,850	–	–	0.64%	47
2023 Q1	$821K	Hold	11,850	–	–	0.7%	42
2022 Q4	$853K	Hold	11,850	–	–	0.76%	37
2022 Q3	$842K	Sell	11,850 -300	-2%	-$21.8K	0.84%	37
2022 Q2	$939K	Hold	12,150	–	–	0.89%	36
2022 Q1	$887K	Hold	12,150	–	–	0.69%	46
2021 Q4	$758K	Buy	+12,150	New	+$713K	0.59%	50

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hedges Asset Management's BMY Position: Q2 2026 in Review

Hedges Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 15,250 shares worth $879K. The stake represents 0.58% of the portfolio and ranks #56 among its holdings. This is a return to the name: Hedges Asset Management previously reported a position in BMY as recently as Q4 2025.

Hedges Asset Management first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.18M in Q1 2025. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hedges Asset Management held 15,250 shares of Bristol-Myers Squibb worth $879K as of Q2 2026.
Bristol-Myers Squibb was a new Hedges Asset Management position in Q2 2026.
Bristol-Myers Squibb made up 0.58% of Hedges Asset Management's portfolio in Q2 2026, its #56 holding.
Hedges Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
Hedges Asset Management's Bristol-Myers Squibb position peaked at $2.18M in Q1 2025.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hedges Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.